MYNZ NASDAQ

Mainz Biomed N.V. - Ordinary Shares

Healthcare · Biotechnology
$0.47
▼ $-0.01 (-1.76%)
Vol 25K
4
Quality Score
fail
Mkt Cap
$10.1M
ROE
-442.8%
Margin
-2874.7%
D/E
77.51
Beta
0.32
52W
$1–$8

Price Chart

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -442.8% -175.8% -175.8% -442.8% -442.8% -442.8%
P/E (TTM) — — — — — —
Net Margin -2910.2% -2421.8% -2421.8% -2874.7% -2874.7% -2874.7%
Gross Margin 66.1% 64.3% 64.3% 67.5% 67.5% 67.5%
D/E Ratio 77.51 37.05 37.05 77.51 77.51 77.51
Current Ratio 0.52 1.32 1.32 0.52 0.52 0.52

Key Ratios

ROA (TTM)
-164.7%
P/S (TTM)
15.38
P/B
1.6
EPS (TTM)
$-10.37
Rev Growth 3Y
+15.5%
52W High
$8.20
52W Low
$0.92
$0.92 52-Week Range $8.20

How does MYNZ compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

MYNZ AAPG ABEO ABOS ABP

MYNZ valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
15.4
▲ 20% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.6
▼ 35% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

MYNZ profitability vs Biotechnology peers

ROE
-442.8%
▼ 558% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-2874.7%
▼ 903% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
67.5%
▼ 14% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-164.7%
▼ 253% below peers (-46.7%)
vs Peers
vs Industry
Weak

MYNZ financial health vs Biotechnology peers

D/E ratio
77.5
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
0.5
▼ 88% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.3
▼ 67% below peers (1.0)
vs Peers
vs Industry
More volatile

MYNZ fundamentals radar

MYNZ Peer median Industry

MYNZ profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

MYNZ vs peers: key metrics

Latest News

No related news yet